Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $6,000 | 2 | 50.7% |
| Unspecified | $3,793 | 2 | 32.0% |
| Food and Beverage | $2,051 | 40 | 17.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amnio Technology, LLC | $6,119 | 3 | $0 (2024) |
| Eli Lilly and Company | $3,793 | 2 | $0 (2018) |
| Pinnacle Transplant Technologies, LLC | $763.03 | 1 | $0 (2019) |
| ABBVIE INC. | $230.64 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $173.66 | 3 | $0 (2021) |
| ARGENX US, INC. | $151.07 | 3 | $0 (2024) |
| Biogen, Inc. | $96.43 | 1 | $0 (2023) |
| GENZYME CORPORATION | $68.35 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $66.29 | 2 | $0 (2024) |
| Lilly USA, LLC | $47.64 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,177 | 9 | Amnio Technology, LLC ($1,000) |
| 2023 | $511.71 | 12 | ABBVIE INC. ($154.93) |
| 2022 | $234.55 | 8 | ARGENX US, INC. ($132.23) |
| 2021 | $251.13 | 8 | Novartis Pharmaceuticals Corporation ($173.66) |
| 2019 | $786.10 | 2 | Pinnacle Transplant Technologies, LLC ($763.03) |
| 2018 | $495.40 | 1 | Eli Lilly and Company ($495.40) |
| 2017 | $8,388 | 4 | Amnio Technology, LLC ($5,000) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Neuroscience | ||||||
| 06/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Amnio Technology, LLC | — | Gift | In-kind items and services | $1,000.00 | General |
| 05/02/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Neurology | ||||||
| 04/03/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: EPILEPSY | ||||||
| 03/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: Central Nervous System | ||||||
| 02/07/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Neurology | ||||||
| 12/09/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $36.14 | General |
| Category: Central Nervous System | ||||||
| 11/14/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $119.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Rare Disease | ||||||
| 10/03/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 07/05/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: PAIN | ||||||
| 06/15/2023 | Amnio Technology, LLC | — | Food and Beverage | Cash or cash equivalent | $119.27 | General |
| 06/07/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Neuroscience | ||||||
| 05/17/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $96.43 | General |
| Category: Neurology | ||||||
| 05/03/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: CNS | ||||||
| 03/02/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2022 | Aprecia Pharmaceuticals, LLC | Spritam (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Decrease CNS Disorganized Electrical Activity [PE] | ||||||
| 11/03/2022 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2022 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: EPILEPSY | ||||||
| 09/08/2022 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $103.38 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND DELAYED-START STUDY OF LY3314814 IN MILD ALZHEIMERS DISEASE DEMENTIA | Eli Lilly and Company | $3,793 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,910 | 16,112 | $8.2M | $482,411 |
| 2022 | 30 | 3,601 | 15,730 | $3.9M | $459,475 |
| 2021 | 33 | 3,197 | 12,619 | $2.4M | $424,805 |
| 2020 | 28 | 2,888 | 12,773 | $2.9M | $346,349 |
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 770 | 1,298 | $280,887 | $111,864 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 395 | 492 | $130,380 | $58,917 | 45.2% |
| 96133 | Evaluation of neuropsychological test, each additional hour | Office | 2023 | 203 | 612 | $94,860 | $46,363 | 48.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 9,100 | $77,350 | $45,208 | 58.4% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 203 | 1,614 | $104,910 | $42,683 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 175 | 175 | $58,184 | $20,619 | 35.4% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 203 | 204 | $42,840 | $19,450 | 45.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 105 | 105 | $43,789 | $16,147 | 36.9% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 203 | 204 | $31,008 | $14,606 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 189 | $28,256 | $12,536 | 44.4% |
| 96121 | Exam of neurobehavioral status, each additional hour | Office | 2023 | 203 | 204 | $28,560 | $11,953 | 41.9% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2023 | 92 | 474 | $948,000 | $10,826 | 1.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 74 | 76 | $29,517 | $10,105 | 34.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 96 | 134 | $24,677 | $10,019 | 40.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 28 | 29 | $24,250 | $9,352 | 38.6% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 266 | 270 | $3.2M | $9,076 | 0.3% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 203 | 204 | $12,240 | $5,239 | 42.8% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2023 | 52 | 54 | $963,901 | $4,780 | 0.5% |
| 95937 | Testing of nerve-muscle junction | Facility | 2023 | 155 | 157 | $994,203 | $3,980 | 0.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 18 | 18 | $8,448 | $2,707 | 32.0% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 23 | 23 | $4,600 | $2,063 | 44.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 17 | 17 | $2,380 | $1,866 | 78.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 27 | 52 | $29,437 | $1,807 | 6.1% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2023 | 32 | 32 | $13,872 | $1,607 | 11.6% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2023 | 52 | 104 | $530,400 | $1,518 | 0.3% |
About Dr. Constantine Moschonas, M.D
Dr. Constantine Moschonas, M.D is a Neurology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205965019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constantine Moschonas, M.D has received a total of $11,844 in payments from pharmaceutical and medical device companies, with $1,177 received in 2024. These payments were reported across 44 transactions from 25 companies. The most common payment nature is "Gift" ($6,000).
As a Medicare-enrolled provider, Moschonas has provided services to 13,596 Medicare beneficiaries, totaling 57,234 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Scottsdale, AZ
- Active Since 03/05/2007
- Last Updated 10/04/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1205965019
Products in Payments
- KESIMPTA (Drug) $173.66
- QULIPTA (Drug) $171.05
- VYVGART (Drug) $132.23
- VUMERITY (Drug) $96.43
- AUBAGIO (Drug) $68.35
- UBRELVY (Drug) $59.59
- ZEPOSIA (Drug) $39.35
- AJOVY (Biological) $36.14
- Austedo XR (Drug) $30.15
- Leqembi (Drug) $29.21
- EMGALITY (Drug) $27.86
- VALTOCO (Drug) $26.69
- SOLIRIS (Biological) $24.98
- Briviact (Drug) $24.16
- IPX203 (Drug) $23.07
- Spritam (Drug) $22.42
- Adlarity (Drug) $22.32
- NAMZARIC (Drug) $21.85
- KISUNLA (Drug) $19.78
- APTIOM (Drug) $19.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Scottsdale
Dr. Nida Laurin, M.d, M.D
Neurology — Payments: $1.2M
Dr. Amaal Starling, M.d, M.D
Neurology — Payments: $314,467
Dr. Dean Wingerchuk, M.d, M.D
Neurology — Payments: $314,438
Dr. Virgilio Evidente, M.d, M.D
Neurology — Payments: $280,162
David Saperstein, Md, MD
Neurology — Payments: $173,854
Dr. Cornelia Drees, M.d, M.D
Neurology — Payments: $171,652